Study results from phase 1 studies with exidavnemab published in The Journal of Clinical Pharmacology ...Middle East

PR Newswire - News
STOCKHOLM, Aug. 27, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the results from two phase-1 studies with exidavnemab have been published in The Journal of Clinical Pharmacology. Exidavnemab is a drug candidate under development aimed at...

Hence then, the article about study results from phase 1 studies with exidavnemab published in the journal of clinical pharmacology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Study results from phase 1 studies with exidavnemab published in The Journal of Clinical Pharmacology )

Apple Storegoogle play

Last updated :

Also on site :